Volume 17, Number 10—October 2011
Dispatch
Bacteremia and Antimicrobial Drug Resistance over Time, Ghana
Table 1
Variable |
July 2001–April 2002 |
July–September 2009 |
|||
Total |
Positive for Plasmodium spp. |
Total |
Positive for Plasmodium spp. |
||
No. patients with fever of unknown origin | 409 | NA | 258 | NA | |
No. Plasmodium spp. positive/total no. tested (%)† | 85/354 (24.0) | NA | 75/177 (42.4) | NA | |
Total no. bacterial isolates | 212 | 51 (24.1) | 99 | 14 (14.1) | |
Skin flora contaminants | 67 | 24 (35.8) | 51 | 10 (19.6) | |
Potential pathogens |
145 (100.0) |
27 (18.6) |
48 (100.0) |
4 (8.3) |
|
Salmonella enterica serovars | 100 (69.0) | 20 (20.0) | 24 (50.0) | 4 (16.7) | |
Typhi | 59 (40.7) | 11 (18.6) | 15 (31.3) | 2 (13.3) | |
Paratyphi | 1 (0.7) | NF | 0 | NF | |
Nontyphoid‡ |
40 (27.6) |
9 (22.5) |
9 (18.8) |
2 (22.2) |
|
Staphylococcus aureus | 16 (11.0) | 3 (18.8) | 3 (6.3) | NF | |
Enterobacteriaceae other than Salmonella spp. | 10 (6.9) | 1 (10.0) | 8 (16.7) | NF | |
Pseudomonas spp. | 7 (4.8) | 2 (28.6) | 5 (10.4) | NF | |
Other§ | 12 (8.3) | 1 (8.3) | 8 (16.7) | NF |
*Values are no. (%) except as indicated. The total number of potential pathogens for each study period was set as 100%. Coagulase-negative staphylococci, microcooci, and bacilli were judged as skin flora contaminants. The ratio of Plasmodium spp.–positive patients in regard to bacterial species respective groups is indicated. NA, not applicable; NF, Plasmodium spp. not found.
†Blood film for Plasmodium spp. was done in most but not all cases. If the clinical situation, patient history, or blood count strongly indicated bacterial infection, blood culture was taken as first diagnostic approach.
‡S. enterica serovar Enteritidis and serovar Typhimurium.
§Including Streptococcus spp., Enterococcus spp., Acinetobacter spp.
Page created: September 26, 2011
Page updated: September 26, 2011
Page reviewed: September 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.